PCSK9 and pancreatic serous cystadenoma: This study demonstrates that serum PCSK9 levels are significantly elevated in patients with autoimmune liver diseases—PSC, PBC, and AIH—regardless of disease severity, liver function parameters, or fibrosis stage.